Author

G. L. Rogers

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Approach:experimental assay· 2 Assay:proteomics· 2 Research Focus:cell type annotation· 1 Assay:CRISPR screen· 1 Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

H.-Y. Chen· 3 shared P. M. Cannon· 3 shared X. Huang· 3 shared C. Huang· 2 shared G. N. Llewellyn· 2 shared A. Mathur· 1 shared C. Zhang· 1 shared C.-H. Chang· 1 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

H.-Y. Chen

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Reprogramming human B cells with custom heavy chain antibodies

G. L. Rogers, C. Huang, A. Mathur, X. Huang, H.-Y. Chen, K. Stanten, H. Morales, C.-H. Chang, E. J. Kezirian, P. M. Cannon

This paper describes a genome editing strategy to reprogram human B cells to express custom heavy chain antibodies that respond to immunization.

bioRxiv · Jun 28, 2023Immunology

Comparison of SARS-CoV-2 entry inhibitors based on ACE2 receptor or engineered Spike-binding peptides

G. N. Llewellyn, H.-Y. Chen, G. L. Rogers, X. Huang, P. Sell, J. E. Henley, P. M. Cannon

This study compares ACE2-derived and engineered Spike-binding peptide entry inhibitors against SARS-CoV-2 variants, finding that an optimized ACE2 derivative neutralizes all tested variants, while peptides show variable efficacy with resistance observed in Beta, Gamma, and Omicron variants.

bioRxiv · Jan 5, 2023 · PreprintMicrobiology

Cytoplasmic tail truncation of SARS-CoV-2 Spike protein enhances titer of pseudotyped vectors but masks the effect of the D614G mutation

H.-Y. Chen, C. Huang, L. Tian, X. Huang, C. Zhang, G. N. Llewellyn, G. L. Rogers, K. Andresen, M. R. G. O'Gorman, Y.-W. Chen, P. M. Cannon

This study shows that truncating the SARS-CoV-2 Spike protein's cytoplasmic tail increases pseudovector titer but masks the D614G mutation's effect on Spike incorporation.

bioRxiv · Jun 21, 2021Microbiology